Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| ajcc staging prostate |
|
Prostate Cancer Stage II prostate cancer is defined by the following staging systems:. American Joint Committee on Cancer's (AJCC) TNM classification system: Utilizing the Tumor-Node-Metastasis Staging for Prostate Cancer Prostate cancer involving the bladder neck: recurrence-free survival and implications for AJCC staging modification. American Joint Committee on Cancer Staging for prostate cancer prostate, this staging system may no longer be ade-. quate for classifying contemporary patients. In parti-. cular, patients with AJCC stage I prostate CAT.INIST The American Joint Committee on Cancer (AJCC) staging system for prostate cancer is based primarily based on clinical tumor (T) classification. The Journal of Urology : ABILITY OF THE 1992 AND 1997 AMERICAN In a revised 1997 edition the American Joint Committee on Cancer (AJCC) staging for prostate cancer reduced the subdivision of T2 disease from 3 (T2a, Online CME -- Deficiencies in AJCC Staging System for Prostate Cancer Deficiencies in AJCC Staging System for Prostate Cancer; No Increase in Recurrent DVT Despite Thrombophilic Risk Factors; Randomized Trial Comparing Literature alert that the 1992 AJCC staging of T2 prostate cancer yielded a significant difference in the outcome of. patients with single lobe disease (T2a92 and T2b92), Prostate Cancer Stages Although in this AJCC staging system, the T, N, M stages are to be combined into a single Roman numeral Iâ“IV, this is not often needed for prostate cancer Nature Clinical Practice Urology | Can the AJCC staging system The current American Joint Committee on Cancer (AJCC) staging system for prostate cancer has limited relevance to newly diagnosed prostate cancer patients Prostate ca staging Prostate Cancer ** AJCC STAGE INFORMATION (Source: PDQ/NCI)**. Primary tumor (T). TX: Primary tumor cannot be assessed; T0: No evidence of primary tumor AJCC Prostate Staging AJCC STAGING FOR PROSTATE CANCER** based on the AJCC Cancer Staging Manual (Fifth Edition 1998) Please select one from each TNM Category |
| ajcc staging prostate |
|
cancer curing prostate back pain prostate cancer cancer diagnosis more prostate test cryosurgery for prostate surgery |